Patents by Inventor Xiaoju Wang
Xiaoju Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11307203Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.Type: GrantFiled: March 23, 2018Date of Patent: April 19, 2022Assignees: The Regents of the University of Michigan, Exact Sciences Development Company, LLCInventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
-
Patent number: 10774122Abstract: The present disclosure relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present disclosure relates to recurrent gene fusions as clinical targets for cancer.Type: GrantFiled: March 19, 2018Date of Patent: September 15, 2020Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Arul Chinnaiyan, Xiaoju Wang
-
Publication number: 20180273595Abstract: The present disclosure relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present disclosure relates to recurrent gene fusions as clinical targets for cancer.Type: ApplicationFiled: March 19, 2018Publication date: September 27, 2018Inventors: Arul Chinnaiyan, Xiaoju Wang
-
Publication number: 20180265861Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.Type: ApplicationFiled: June 4, 2018Publication date: September 20, 2018Inventors: Arul M. Chinnaiyan, Xiaoju Wang
-
Publication number: 20180224455Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.Type: ApplicationFiled: March 23, 2018Publication date: August 9, 2018Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
-
Patent number: 10006023Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.Type: GrantFiled: January 12, 2016Date of Patent: June 26, 2018Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Arul M. Chinnaiyan, Xiaoju Wang
-
Patent number: 9658231Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.Type: GrantFiled: August 10, 2015Date of Patent: May 23, 2017Assignees: The Regents of the University of Michigan, Armune Biosciences, Inc.Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
-
Publication number: 20160264959Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.Type: ApplicationFiled: January 12, 2016Publication date: September 15, 2016Inventors: Arul M. Chinnaiyan, Xiaoju Wang
-
Patent number: 9267133Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.Type: GrantFiled: October 28, 2010Date of Patent: February 23, 2016Assignee: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Arul Chinnaiyan, Xiaoju Wang
-
Publication number: 20160041174Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.Type: ApplicationFiled: August 10, 2015Publication date: February 11, 2016Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
-
Patent number: 8759301Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.Type: GrantFiled: February 10, 2011Date of Patent: June 24, 2014Assignee: The Regents of The University of MichiganInventors: Arul M. Chinnaiyan, Xiaoju Wang, Ram Shankar Mani
-
Patent number: 8617547Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer.Type: GrantFiled: September 10, 2009Date of Patent: December 31, 2013Assignee: The Regents of The University of MichiganInventors: Arul Chinnaiyan, David Beer, Guoan Chen, Xiaoju Wang
-
Publication number: 20110237461Abstract: The present disclosure provides compositions and methods for using one or more polypeptide probes to profile an immune response. The polypeptide probe can be used to detect one or more antibodies from a sample. Furthermore, the present disclosure provides methods and compositions for characterizing a cancer based on the detection of one or more antibodies, such as autoantibodies.Type: ApplicationFiled: March 17, 2011Publication date: September 29, 2011Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, ARMUNE BIOSCIENCES, INC.Inventors: Arul M. Chinnaiyan, Xiaoju Wang, Alex Tsodikov, Jeanne Ohrnberger
-
Publication number: 20110207675Abstract: The present invention relates to compositions and methods for cancer therapy, including but not limited to, targeted inhibition of cancer markers. In particular, the present invention relates to recurrent gene fusions as clinical targets for prostate cancer.Type: ApplicationFiled: February 10, 2011Publication date: August 25, 2011Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Arul M. Chinnaiyan, Xiaoju Wang, Ram Shankar Mani
-
Publication number: 20110070652Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.Type: ApplicationFiled: October 28, 2010Publication date: March 24, 2011Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: ARUL CHINNAIYAN, XIAOJU WANG
-
Patent number: 7858323Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.Type: GrantFiled: June 6, 2005Date of Patent: December 28, 2010Assignee: The Regents of the University of MichiganInventors: Arul Chinnaiyan, Xiaoju Wang
-
Publication number: 20100009382Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer.Type: ApplicationFiled: September 10, 2009Publication date: January 14, 2010Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGANInventors: Arul Chinnaiyan, David Beer, Guoan Chen, Xiaoju Wang
-
Patent number: 7597890Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer.Type: GrantFiled: March 8, 2007Date of Patent: October 6, 2009Assignee: The Regents of the University of MichiganInventors: Arul Chinnaiyan, David Beer, Guoan Chen, Xiaoju Wang
-
Publication number: 20080044839Abstract: The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to ubiquilin 1 markers for cancer.Type: ApplicationFiled: March 8, 2007Publication date: February 21, 2008Applicant: Regents of the University of MichiganInventors: Arul Chinnaiyan, David Beer, Guoan Chen, Xiaoju Wang
-
Publication number: 20060014138Abstract: The present invention relates to compositions and methods for cancer diagnostics, including but not limited to, cancer markers. In particular, the present invention provides methods and compositions for phage microarray profiling of cancer (e.g., prostate, lung, or breast cancer). The present invention further provides novel markers useful for the diagnosis, characterization, and treatment of cancers.Type: ApplicationFiled: June 6, 2005Publication date: January 19, 2006Applicant: The Regents of the University of MichiganInventors: Arul Chinnaiyan, Xiaoju Wang
